Indications / Contraindications
Indications for Revision
- TIPS stenosis on Duplex US: intrastent velocity >200 cm/s OR velocity change >50 cm/s between segments suggests stenosis; also mVPmax <28 cm/s (hepatofugal) or <39 cm/s (hepatopetal) per AASLD; loss of phasic waveform; or PPG >12 mmHg on catheter measurement. Normal post-TIPS intrastent flow is hepatofugal, typically 90–190 cm/s.
- Recurrent variceal hemorrhage with known TIPS — strongly suggests shunt dysfunction; proceed directly to catheter lab
- Recurrent or refractory ascites post-TIPS — may indicate inadequate shunt function
- TIPS thrombosis (complete occlusion) — requires mechanical and/or thrombolytic recanalization
Indication for TIPS Reducer
- Refractory post-TIPS hepatic encephalopathy not controlled with lactulose and rifaximin
- Goal: reduce shunt diameter (e.g., 8 mm → 6 mm) without full occlusion to preserve partial portal decompression while reducing ammonia shunting
Contraindications
- Active uncontrolled sepsis or bacteremia (relative; treat infection first)
- Complete TIPS occlusion with no residual lumen and inaccessible portal vein (requires fresh portal vein puncture)
- Worsening liver failure prohibiting further intervention (clinical judgment)
- INR >2.5 uncorrectable — correct with FFP/PCC before revision
Pre-Procedure Checklist
Relevant Anatomy
Common Stenosis Locations
- Outflow at hepatic vein–IVC junction: most common stenosis site; intimal hyperplasia at stent flare; responds to angioplasty ± stent extension into IVC
- Intrastent pseudointimal hyperplasia: diffuse throughout bare metal stent; requires covered stent extension for durable treatment
- Inflow at portal vein end: fibrous ingrowth at uncovered segment; balloon angioplasty ± covered stent extension into portal vein
Stent-Specific Anatomy
- Bare metal stents (legacy TIPS): pseudointimal ingrowth throughout stent lumen; angioplasty alone has 40–60% restenosis rate; always require covered stent extension
- Viatorr (covered): ePTFE-covered central segment with bare metal portal end; stenosis typically at uncovered portal segment or at hepatic vein flare
- Portal vein thrombosis: may extend from TIPS inflow into main portal vein; requires thrombolysis ± mechanical thrombectomy before stent revision
Technique
Default RadCall approach · share your own below
Supplies
Steps — Standard Revision
Right IJV Access
Catheterize Existing TIPS Stent
Traverse Stent to Portal Vein
Pressure Measurement
Venography
Stenosis Treatment
Thrombosed TIPS (if applicable)
Post-Revision Pressure & Venogram
Constrained TIPS Technique — Controlled Diameter Reduction
Used when a smaller shunt diameter is desired from the outset (e.g., high-risk encephalopathy patient, Child-Pugh B/C) without committing to a full 10 mm shunt. The "waist" technique limits shunt diameter and can reduce early encephalopathy while still achieving adequate portal decompression.
Device Selection
Method A — Balloon Under-Expansion
Method B — Sheath-Constrained Deployment
Pressure-Guided Titration
Steps — TIPS Reducer (Refractory Encephalopathy)
Catheterize Existing TIPS via Right IJV
Baseline PPG Measurement
Deploy TIPS Reducer Device
Confirm Pressure Response
Troubleshooting
Cannot enter original TIPS stent lumen
Likely cause: Complete thrombosis, stent migration, or severe kinking preventing wire passage
Next step: CO2 venography to opacify stent. Try angled hydrophilic wire (Glidewire). If truly occluded: fresh portal vein puncture under ICE guidance (parallel TIPS). Do not force wire through a fully occluded stent.
Cannot cross intrastent stenosis with wire
Likely cause: Dense fibrous pseudointimal tissue in old bare metal stents
Next step: Try hydrophilic angled wire (Glidewire Advantage). Pre-dilate with small 4 mm balloon to crack fibrous tissue. Exchange for stiff wire once across for definitive balloon dilation.
PPG remains elevated after stent revision
Likely cause: Competing collateral inflow, inadequate stent sizing, or second stenosis not yet addressed
Next step: Portal venogram to identify large collaterals. If present: coil embolize coronary or short gastric veins. Balloon-expand stent to maximum diameter. Measure PPG sequentially at each level to localize residual gradient.
Complications
Immediate
- Intra-abdominal hemorrhage (rare) — capsular puncture or hepatic vein/IVC perforation
- Hemobilia — biliary injury during wire manipulation
- Arterial injury — hepatic artery during aggressive wire maneuvers
- Pulmonary embolism if thrombolysis dislodges large portal clot
Delayed
- Re-stenosis — especially with bare metal stent extension; covered stent provides more durable patency
- Hepatic encephalopathy worsening — after shunt re-opening or diameter increase from revision
- Stent migration — rare with covered stents; more common with bare metal
- Coagulopathy post-thrombolysis — fibrinogen depletion; monitor fibrinogen level post-infusion; target >100 mg/dL
Post-Procedure Care
Immediate Monitoring
- Duplex US at 1 month post-revision — confirm shunt patency and re-established flow velocity; earlier Doppler if clinical concern (recurrent symptoms, deterioration)
- If thrombolysis performed: check fibrinogen at end of infusion; transfuse FFP if fibrinogen <100 mg/dL
- Neurologic checks post-procedure — especially if shunt diameter was increased
- CBC and CMP at 6h
Surveillance & Outpatient Plan
- Resume standard TIPS surveillance: Duplex US at 1 month post-revision, then q6 months
- Hepatic encephalopathy monitoring — increased vigilance in first 4–6 weeks if shunt diameter was increased
- Reassess clinical response (ascites, variceal bleed-free status) at 4–6 week clinic visit
- For TIPS reducer: reassess encephalopathy grade and PPG at 4–6 weeks; titrate medical management
Critical Pearls
References & Resources
Key Guidelines
- SIR Standards of Practice: TIPS (2016)
- AASLD Portal Hypertension Guidelines (2021)
Primary References
- Haskal ZJ, et al. Stent-graft for revision of transjugular intrahepatic portosystemic shunts. N Engl J Med. 1997;336(4):233–239.
- Maleux G, et al. Endovascular management of transjugular intrahepatic portosystemic shunt dysfunction. Eur Radiol. 2004;14(5):827–836. PMID 15221261.
- Clark TWI, et al. Management of shunt dysfunction in the era of TIPS endografts. Tech Vasc Interv Radiol. 2008;11(4):212–216. PMID 19527847.